---
figid: PMC7922739__cancers-13-00856-g002
figtitle: An overview of targeted therapies in GBM
organisms:
- Adenoviridae
- Vaccinia virus
- Enterovirus
- Myxoma virus
- Homo sapiens
- Mus musculus
- Alburnus alburnus
- NA
organisms_ner:
- Drosophila melanogaster
pmcid: PMC7922739
filename: cancers-13-00856-g002.jpg
figlink: pmc/articles/PMC7922739/figure/cancers-13-00856-f002/
number: F2
caption: An overview of targeted therapies in GBM. Classification of current targeted
  therapies in GBM according to the three main signaling pathway alterations of the
  P53, Rb, and RTK pathways.
papertitle: Pathogenetic Features and Current Management of Glioblastoma.
reftext: Hong-My Nguyen, et al. Cancers (Basel). 2021 Feb;13(4):856.
year: '2021'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.5743275
figid_alias: PMC7922739__F2
figtype: Figure
redirect_from: /figures/PMC7922739__F2
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7922739__cancers-13-00856-g002.html
  '@type': Dataset
  description: An overview of targeted therapies in GBM. Classification of current
    targeted therapies in GBM according to the three main signaling pathway alterations
    of the P53, Rb, and RTK pathways.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - p53
  - betaTub60D
  - hth
  - rb
  - Tie
  - Ras85D
  - InR
  - btl
  - htl
  - HDAC4
  - HDAC6
  - HDAC1
  - HDAC3
  - Cdk4
  - Egfr
  - APR
  - Pegdinetanib
  - Cediranib
  - Sunitinib
  - Pazopanib
  - PEITC
  - RG7112
  - TSA
  - Erlotinib
  - Osimetinib
  - Erdafitinib
  - AZD4547
  - AMG232
  - Temsirolimus
  - Everolimus
  - Capmatinib
  - Nintedanib
  - Brivanib
  - Vandetanib
  - Sorafenib
  - Lenvatinib
  - Cabozantinib
---
